Company at a Glance

Memphis Pharmaceuticals & Chemical Industries (MPCI)

Official Name: Memphis Pharmaceuticals & Chemical Industries (MPCI)

Type: Public Joint-Stock Company Listed on the Egyptian Stock Exchange

Founded: Around 1940, with operations active since the mid-20th century in the pharmaceutical and chemical industries.

Headquarters: El-Sawah Street, Amiriya, Cairo, Egypt

Affiliation: Part of the "Holdipharma" Group (The Holding Company for Pharmaceuticals, Chemicals, and Medical Supplies), which owns the majority of its shares (~60%).


Activities & Products

The company is engaged in research and development, manufacturing, marketing, and distribution of pharmaceutical products for both human and veterinary use at local and international levels.

Its Products Cover a Wide Range of Therapeutic Areas, Including:

  1. Anti-Infectives
  2. Central Nervous System (CNS)
  3. Dermatology
  4. Cardiovascular Diseases
  5. Corticosteroids
  6. Vitamins and Minerals
  7. Analgesics and Antipyretics
  8. Respiratory System
  9. Gastrointestinal and Metabolic Disorders
  10. And other therapeutic fields

The company also manufactures veterinary health products in forms such as powders, oral solutions, and injections.

Additionally, it is involved in the production of cosmetics and certain veterinary additives (feed supplements or specific additives).